Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

AUPH holding history

Aurinia Pharmaceuticals Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AUPH overview All 13F holders of AUPH Full Q1 2026 holdings

Shares (Q3 2023): 0; Sold out in Q3 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2023

Holdings of AUPH by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2023	0	$0	0.0%	−23,391−100.0%	Sold out	Holders
Q2 2023	23,391	$226.4K	0.2%	+10,578+82.6%	Added	Holders
Q1 2023	12,813	$140.4K	0.2%	–	No prior filing	Holders